Kin Tse

Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy

M. Harrison, M. Morris, H. Scher, 2021, European Urology Open Science.

Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer.

N. Bander, M. Morris, H. Scher, 2016, Urologic oncology.

Phase II study of docetaxel and epirubicin in Chinese patients with metastatic breast cancer

T. Mok, W. Yeo, P. Johnson, 2002, Anti-cancer drugs.

Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer.

N. Bander, M. Morris, H. Scher, 2016, Urologic oncology.